Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

KNSAKNSA
9 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in KINIKSA PHARMACEUTICALS INTL

CITADEL ADVISORS LLC holds 41,665 shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $2.7M as of 2026-Q2. The position was decreased (-91.2% shares). KNSA represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$2.7M

Current Shares

41,665

Total Value Change

+$1.6M

Total Shares Change

-13,155

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
41,665
-91.2%
$2.7M0.0%$63.95
0
2026-Q1
Decreased
474,750
-36.0%
$22.9M0.0%$45.37
0
2025-Q4
Increased
742,118
+135.9%
$30.6M0.0%$40.99
46
2025-Q3
Increased
314,556
+17.6%
$12.2M0.0%$38.77
33
2025-Q2
Increased
267,393
+340.9%
$7.4M0.0%$28.04
44
2025-Q1
Decreased
60,647
-80.1%
$1.3M0.0%$23.09
0
2024-Q4
Increased
304,576
+53.5%
$6M0.0%$19.60
38
2024-Q3
Increased
198,413
+261.9%
$5M0.0%$25.00
43
2024-Q2
New
54,820
-
$1M0.0%$18.67
35

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used